MACK   $15.105  -0.10% Market Closed

Merrimack Pharmaceuticals Inc
Total Cash 18.88M
totalCashPerShare 1.3
EBITDA
Total Debt 0.00
quickRatio 42.8
currentRatio 43.501
Total Revenue
debtToEquity
Revenue/Share
ROA -0.069699995
ROE -0.06217
grossProfits
freeCashflow -1.13M
operatingCashflow -1.52M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 194.22M
forwardPE
floatShares 9.40M
sharesOutstanding 14.53M
sharesShort 722.75K
sharesShortPriorMonth 774.10K
dateShortInterest
sharesPercentSharesOut 0.05%
heldPercentInsiders 0.01%
heldPercentInstitutions 0.67%
Short Ratio help_outline 6.23%
shortPercentOfFloat 0.07%
impliedSharesOutstanding
bookValue 1.306
Price To Book help_outline 11.24
earningsQuarterlyGrowth
netIncomeToCommon -1.18M
trailingEps -0.08%
forwardEps -1.78%
enterpriseToEbitda
lastDividendValue
lastDividendDate
currentQuarterEstimate 4Q 2018
institutionsCount 96
lastUpdated April 16, 2024, 4:24 p.m.